A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium

Published:2024-07 Issue:4 Volume:4 Page:100502
ISSN:2666-9145
Container-title:Ophthalmology Science
language:en
Short-container-title:Ophthalmology Science

Author:

Whitcup Scott M.^ORCID,Sall Kenneth N.,Hovanesian John A.,Goldberg Damien F.,Lee Olivia L.,Yang Rong,Ni Jinsong

Funder

National Eye Institute

Publisher

Elsevier BV

Reference33 articles.

1. Pterygium pathogenesis, actinic damage, and recurrence;Chui,2012

2. Prevalence of pterygium in the United States: a claims-based analysis;Abraham;Invest Ophthalmol Vis Sci,2023

3. Pterygium in adults from the Brazilian Amazon Region: prevalence, visual status and refractive errors;Fernandes;Br J Ophthalmol,2020

4. Pterygium Surgery;Buratto,2000

5. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases;Di Girolamo;Prog Retin Eye Res,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP